featured
Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) as a Screening Marker for Familial Adenomatous Polyposis (FAP)
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Ophthalmology (Auckland, N.Z.)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) as a Screening Marker for Familial Adenomatous Polyposis (FAP): Systematic Literature Review and Screening Recommendations
Clin Ophthalmol 2022 Apr 01;16(2022)765-774, LA Bonnet, RM Conway, LA LimFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.